Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid

Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared...

Full description

Bibliographic Details
Main Authors: Stephanie Goletz, Federica Giurdanella, Maike M. Holtsche, Miranda Nijenhuis, Barbara Horvath, Gilles F. H. Diercks, Detlef Zillikens, Takashi Hashimoto, Enno Schmidt, Hendri H. Pas
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.773720/full
_version_ 1818425747950272512
author Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
author_facet Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
author_sort Stephanie Goletz
collection DOAJ
description Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared two independently developed diagnostic indirect immunofluorescence (IF) tests based on recombinant laminin 332 expressed in HEK239 cells (biochip mosaic assay) and the migration trails of cultured keratinocytes rich in laminin 332 (footprint assay). The sera of 54 anti-laminin 332 MMP, 35 non-anti-laminin 332 MMP, and 30 pemphigus vulgaris patients as well as 20 healthy blood donors were analyzed blindly and independently. Fifty-two of 54 and 54/54 anti-laminin 332 MMP sera were positive in the biochip mosaic and the footprint assay, respectively. In the 35 non-anti-laminin 332 MMP sera, 3 were positive in both tests and 4 others showed weak reactivity in the footprint assay. In conclusion, both assays are easy to perform, highly sensitive, and specific, which will further facilitate the diagnosis of anti-laminin 332 MMP.
first_indexed 2024-12-14T14:18:52Z
format Article
id doaj.art-ababc5e370bd45299b68ae0f420b8693
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T14:18:52Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ababc5e370bd45299b68ae0f420b86932022-12-21T22:58:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-11-011210.3389/fimmu.2021.773720773720Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane PemphigoidStephanie Goletz0Federica Giurdanella1Maike M. Holtsche2Miranda Nijenhuis3Barbara Horvath4Gilles F. H. Diercks5Detlef Zillikens6Takashi Hashimoto7Enno Schmidt8Enno Schmidt9Hendri H. Pas10Lübeck Institute for Experimental Dermatology (LIED), University of Lübeck, Lübeck, GermanyCenter for Blistering Diseases, University of Groningen, Groningen, NetherlandsDepartment of Dermatology, University of Lübeck, Lübeck, GermanyCenter for Blistering Diseases, University of Groningen, Groningen, NetherlandsCenter for Blistering Diseases, University of Groningen, Groningen, NetherlandsCenter for Blistering Diseases, University of Groningen, Groningen, NetherlandsDepartment of Dermatology, University of Lübeck, Lübeck, GermanyDepartment of Dermatology, Kurume University School of Medicine, Kurume, JapanLübeck Institute for Experimental Dermatology (LIED), University of Lübeck, Lübeck, GermanyDepartment of Dermatology, University of Lübeck, Lübeck, GermanyCenter for Blistering Diseases, University of Groningen, Groningen, NetherlandsAnti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared two independently developed diagnostic indirect immunofluorescence (IF) tests based on recombinant laminin 332 expressed in HEK239 cells (biochip mosaic assay) and the migration trails of cultured keratinocytes rich in laminin 332 (footprint assay). The sera of 54 anti-laminin 332 MMP, 35 non-anti-laminin 332 MMP, and 30 pemphigus vulgaris patients as well as 20 healthy blood donors were analyzed blindly and independently. Fifty-two of 54 and 54/54 anti-laminin 332 MMP sera were positive in the biochip mosaic and the footprint assay, respectively. In the 35 non-anti-laminin 332 MMP sera, 3 were positive in both tests and 4 others showed weak reactivity in the footprint assay. In conclusion, both assays are easy to perform, highly sensitive, and specific, which will further facilitate the diagnosis of anti-laminin 332 MMP.https://www.frontiersin.org/articles/10.3389/fimmu.2021.773720/fullautoantibodyblisteringbiochipcancerfootprintlaminin 332
spellingShingle Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
Frontiers in Immunology
autoantibody
blistering
biochip
cancer
footprint
laminin 332
title Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_full Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_fullStr Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_full_unstemmed Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_short Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_sort comparison of two diagnostic assays for anti laminin 332 mucous membrane pemphigoid
topic autoantibody
blistering
biochip
cancer
footprint
laminin 332
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.773720/full
work_keys_str_mv AT stephaniegoletz comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT federicagiurdanella comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT maikemholtsche comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT mirandanijenhuis comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT barbarahorvath comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT gillesfhdiercks comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT detlefzillikens comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT takashihashimoto comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT ennoschmidt comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT ennoschmidt comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT hendrihpas comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid